|
🐜
|
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
29 auth.
K. Lauper,
M. Iudici,
D. Mongin,
S. Bergstra,
D. Choquette,
C. Codreanu,
R. Cordtz,
D. De Cock,
L. Dreyer,
O. Elkayam,
E. Hauge,
D. Huschek,
K. Hyrich,
F. Iannone,
N. Inanç,
...
L. Kearsley‐Fleet,
E. Kristianslund,
T. Kvien,
B. Leeb,
G. Lukina,
D. Nordström,
K. Pavelka,
M. Pombo-Suárez,
Ž. Rotar,
M. Santos,
Anja Strangfeld,
P. Verschueren,
D. Courvoisier,
A. Finckh
|
6 |
2022 |
6
🐜
|
|
🐜
|
IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults
8 auth.
A. Hočevar,
Ž. Rotar,
V. Jurčič,
J. Pižem,
S. Čučnik,
A. Vizjak,
...
Rianne van den Broeke,
M. Tomšič
|
6 |
2016 |
6
🐜
|
|
🐜
|
Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis
7 auth.
A. Hočevar,
Ž. Rotar,
R. Ješe,
S. Šemrl,
J. Pižem,
M. Hawlina,
...
M. Tomšič
|
5 |
2016 |
5
🐜
|
|
🐜
|
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
32 auth.
L. Ørnbjerg,
C. H. Brahe,
J. Askling,
A. Ciurea,
H. Mann,
F. Onen,
E. Kristianslund,
D. Nordström,
M. Santos,
C. Codreanu,
J. Gómez-Reino,
Ž. Rotar,
B. Gudbjornsson,
D. di Giuseppe,
M. Nissen,
...
K. Pavelka,
M. Birlik,
T. Kvien,
K. Eklund,
A. Barcelos,
R. Ionescu,
C. Sánchez-Piedra,
M. Tomšič,
Á. Geirsson,
A. Loft,
I. E. van der Horst-Bruinsma,
G. Jones,
F. Iannone,
L. Hyldstrup,
N. Krogh,
M. Hetland,
M. Østergaard
|
5 |
2019 |
5
🐜
|
|
🐜
|
Incidence of IgA vasculitis in the adult Slovenian population
8 auth.
A. Hočevar,
Ž. Rotar,
J. Ostrovršnik,
V. Jurčič,
A. Vizjak,
M. Dolenc Voljč,
...
J. Lindič,
M. Tomšič
|
5 |
2014 |
5
🐜
|
|
🐜
|
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
26 auth.
D. Courvoisier,
K. Chatzidionysiou,
D. Mongin,
K. Lauper,
X. Mariette,
J. Morel,
J. Gottenberg,
S. Bergstra,
M. Suárez,
C. Codreanu,
T. Kvien,
M. Santos,
K. Pavelka,
M. Hetland,
J. Askling,
...
C. Turesson,
S. Kubo,
Yoshiya Tanaka,
F. Iannone,
D. Choquette,
D. Nordström,
Ž. Rotar,
G. Lukina,
C. Gabay,
R. V. van Vollenhoven,
A. Finckh
|
5 |
2020 |
5
🐜
|
|
🐬
|
Does leflunomide have a role in giant cell arteritis? An open-label study
A. Hočevar,
R. Ješe,
Ž. Rotar,
M. Tomšič
|
5 |
2018 |
5
🐬
|
|
🐜
|
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements
10 auth.
P. Žigon,
A. Podovšovnik,
A. Ambrožič,
M. Tomšič,
A. Hočevar,
N. Gašperšič,
...
Ž. Rotar,
S. Praprotnik,
S. Šemrl,
S. Čučnik
|
5 |
2018 |
5
🐜
|
|
🐬
|
The role of colour doppler ultrasonography of facial and occipital arteries in patients with giant cell arteritis: A prospective study.
R. Ješe,
Ž. Rotar,
M. Tomšič,
A. Hočevar
|
5 |
2017 |
5
🐬
|
